Jun 25, 2026
17 MIN READ

How Ozempic Affects Your Blood Work: A Guide to Monitoring Your Health Journey

Semaglutide therapy triggers measurable shifts in your blood chemistry, from glucose control to liver function and kidney markers. Understanding these changes helps you stay safe and track your metabolic progress during treatment.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 25, 2026
17 MIN READ

how ozempic affects your blood work: a guide to monitoring your health journey — PlexusDx GLP-1 education

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When you start semaglutide injections, your body's chemistry begins a profound shift. Studies show that GLP-1 receptor agonists lower fasting glucose by 20–30 mg/dL within weeks, but other blood markers change too—some beneficial, some requiring monitoring. Knowing what to expect from your lab work helps you make informed decisions about your treatment journey.

Blood Sugar and Insulin Changes on Semaglutide Therapy

Semaglutide works by slowing stomach emptying and signaling fullness to the brain, which indirectly improves how your body handles glucose. Your fasting blood glucose typically drops within the first 2–4 weeks of consistent dosing. Hemoglobin A1C—a three-month average of blood sugar—falls gradually, usually showing meaningful improvement by month 3 of therapy.

Insulin levels often decline alongside glucose control because your pancreas faces less demand to produce insulin when blood sugar stays more stable. This reduction is a sign that your metabolic health is improving, not worsening. For many patients, this shift reduces their insulin resistance score, measured as HOMA-IR, which tracks how efficiently your body processes glucose.

Liver Function and Pancreatic Enzyme Monitoring During Treatment

Your doctor will want baseline liver function tests (AST, ALT, bilirubin) before you start semaglutide injections, then recheck them at 6–8 weeks and periodically thereafter. While serious liver injury is rare, GLP-1 therapy can occasionally cause mild enzyme elevation, especially if you have underlying fatty liver disease. Monitoring catches any problems early, when simple adjustments—like dose timing or dietary changes—often resolve the issue.

Amylase and lipase, enzymes produced by the pancreas, may rise slightly in some patients on semaglutide, though clinically significant pancreatitis is uncommon. Your baseline pancreatic enzyme levels help establish what's normal for your body. If levels climb above 3 times the normal range with abdominal pain, your prescriber should pause treatment and investigate.

Kidney Function Markers and Electrolyte Balance

Semaglutide can affect kidney function indirectly through dehydration if you don't drink enough water during weight loss. Your prescriber will order creatinine and eGFR (estimated glomerular filtration rate) at baseline and every 3–6 months to ensure your kidneys continue filtering waste normally. Electrolytes like sodium and potassium should also be checked, since rapid weight loss sometimes shifts fluid balance.

If your eGFR drops more than 10% from baseline, your doctor may adjust your semaglutide dose or frequency, or ask you to increase hydration. People with existing chronic kidney disease need extra careful monitoring, but semaglutide itself is considered kidney-safe for most patients when used with proper oversight. PlexusDx partners with licensed compounding pharmacies that provide clear guidance on baseline testing and follow-up schedules.

Cholesterol, Triglycerides, and Cardiovascular Markers

Weight loss from semaglutide therapy typically improves your lipid panel—total cholesterol, LDL, and triglycerides all often decrease by 10–20% as you shed pounds. Your HDL (good cholesterol) may rise modestly as well, reflecting improved cardiovascular health. These lipid changes usually appear by 8–12 weeks of consistent therapy and improve further as weight loss continues.

Some patients see unexpected small increases in LDL cholesterol early in treatment, likely because rapid fat breakdown releases stored cholesterol into the bloodstream. This temporary shift usually reverses within weeks as your body reabsorbs the cholesterol into new tissue. Your doctor will monitor LDL trends over time rather than reacting to a single reading, ensuring true cardiovascular benefit rather than normal metabolic fluctuation.

Thyroid and Metabolic Hormone Testing During Semaglutide Use

Thyroid function (TSH, free T4) should be checked at baseline and annually during semaglutide therapy, since weight loss itself can shift thyroid hormone levels. GLP-1 medications do not directly affect the thyroid, but rapid weight loss may uncover a pre-existing thyroid condition. If your TSH creeps upward during treatment, your doctor can add thyroid medication if needed or adjust your semaglutide dose timing.

Cortisol and other stress hormones may improve on semaglutide as weight decreases and metabolic stress lessens. Leptin, the hormone that signals fullness, often drops as you lose fat mass—this is expected and not harmful. The PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptide interactions, helping your prescriber predict which hormonal shifts you're most likely to experience based on your genetic makeup.

Creating Your Blood Work Monitoring Schedule with PlexusDx

A complete baseline blood panel before starting semaglutide injections should include glucose, A1C, liver enzymes (AST, ALT, bilirubin), amylase, lipase, creatinine, eGFR, electrolytes (sodium, potassium), lipid panel, and TSH. After you begin therapy, most patients recheck labs at 6 weeks, 12 weeks, and then every 6 months if everything is stable. If you have diabetes, kidney disease, or liver concerns, your prescriber may recommend more frequent checks.

PlexusDx recommends discussing a personalized testing timeline with your prescriber before your first semaglutide injection. The Precision Peptide Genetic Test ($99 add-on after your first month) identifies genetic variants in GLP1R, GIPR, FTO, and MC4R that predict how your body will metabolize medication and respond to weight loss, helping your doctor anticipate which blood markers need closest attention. Semaglutide Injection starts at $149 per month with no insurance required, so you can focus on health, not billing delays.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will my blood sugar drop too low on semaglutide if I'm not diabetic?

Dangerously low blood sugar (hypoglycemia) is rare on semaglutide alone in non-diabetic patients because the medication only increases insulin release when glucose is already elevated. If you combine semaglutide with diabetes medications like sulfonylureas or insulin, your risk of low blood sugar rises, which is why your prescriber reviews your full medication list. Regular blood glucose monitoring helps catch any unexpected drops early.

How often should I get blood work done while on semaglutide injections?

Start with a complete baseline panel before your first injection, then recheck at 6 weeks and 12 weeks. After that, most stable patients need labs every 6 months, though people with diabetes, kidney disease, or liver issues may need checks every 3 months. Your PlexusDx prescriber will create a schedule tailored to your health history and baseline results.

Can semaglutide damage my liver or kidneys?

Serious liver or kidney damage from semaglutide is extremely rare when used as directed with proper monitoring. Mild liver enzyme elevation occurs in fewer than 5% of patients and usually resolves without stopping treatment. Kidney function typically stays stable or improves with weight loss, but dehydration during rapid weight loss can temporarily lower kidney function—staying hydrated and getting checked regularly prevents problems.

Why did my cholesterol go up slightly when I started semaglutide?

A temporary small rise in LDL cholesterol early in semaglutide therapy often reflects rapid fat breakdown releasing stored cholesterol into your bloodstream; this reverses within weeks. Overall, weight loss from semaglutide improves lipid panels by 10–20% within 8–12 weeks. Your doctor monitors the trend over several months rather than reacting to one reading.

Does the PlexusDx Precision Peptide Genetic Test predict my blood work changes?

The Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R that influence how your body responds to semaglutide and handles glucose, fat, and appetite signaling. These genetic insights help your prescriber predict which blood markers—glucose, insulin, lipids, or weight loss speed—you're most likely to shift, enabling personalized monitoring and dose planning. The test costs $99 and is available after your first month of treatment.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves